Atul Saran

2021 - Emergent BioSolutions

In 2021, Atul Saran earned a total compensation of $2.1M as Executive Vice Presidentand Chief Strategy andand Development Officer at Emergent BioSolutions, a 4% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$258,075
Option Awards$549,630
Salary$553,885
Stock Awards$700,054
Other$8,700
Total$2,070,344

Saran received $700.1K in stock awards, accounting for 34% of the total pay in 2021.

Saran also received $258.1K in non-equity incentive plan, $549.6K in option awards, $553.9K in salary and $8.7K in other compensation.

Rankings

In 2021, Atul Saran's compensation ranked 5,923rd out of 12,406 executives tracked by ExecPay. In other words, Saran earned more than 52.3% of executives.

ClassificationRankingPercentile
All
5,923
out of 12,406
52nd
Division
Manufacturing
2,504
out of 5,494
54th
Major group
Chemicals And Allied Products
1,089
out of 2,369
54th
Industry group
Drugs
969
out of 2,090
54th
Industry
Pharmaceutical Preparations
698
out of 1,537
55th

Pay ratio

Atul Saran's Pay$2,070,344
Median Employee's Pay$110,416
Pay Ratio

19

to 1

In 2021, the annual total compensation of Atul Saran was $2,070,344.

The annual total compensation of the median employee at Emergent BioSolutions was $110,416.

The ratio of Atul Saran's pay to the pay of median employee was therefore 19 to one.

Source: SEC filing on April 15, 2022.

Saran's colleagues

We found four more compensation records of executives who worked with Atul Saran at Emergent BioSolutions in 2021.

2021

Robert Kramer

Emergent BioSolutions

Chief Executive Officer

2021

Fuad El-Hibri

Emergent BioSolutions

Chairman

2021

Richard Lindahl

Emergent BioSolutions

Chief Financial Officer

2021

Adam Havey

Emergent BioSolutions

Chief Operating Officer

News

You may also like